A Phase 1b, Open-Label, Multicenter Study Evaluating the Safety, Tolerability and Efficacy of Xaluritamig in Subjects with High-Risk Biochemical Recurrence of non- Metastatic Castration Sensitive Prostate Cancer After Definitive Therapy

Project: Research

Project Details

StatusActive
Effective start/end date13/09/24 → 12/09/26

Keywords

  • Clinical Trials
  • 20230238